
Results
12
Companies which are potentially undervalued and in an acceptable financial position.
12 companies
Otsuka Holdings
Market Cap: JP¥5.5t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,360.00
7D
0.8%
1Y
44.1%
Kissei Pharmaceutical
Market Cap: JP¥165.0b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,980.00
7D
3.1%
1Y
-4.0%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,809.00
7D
1.5%
1Y
12.5%
Sumitomo Pharma
Market Cap: JP¥667.1b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,487.00
7D
1.7%
1Y
45.5%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,259.00
7D
2.1%
1Y
44.3%
Astellas Pharma
Market Cap: JP¥3.8t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,144.00
7D
-0.02%
1Y
55.0%
Chugai Pharmaceutical
Market Cap: JP¥12.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,523.00
7D
2.0%
1Y
1.9%
Daiichi Sankyo Company
Market Cap: JP¥4.6t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,519.50
7D
-1.5%
1Y
-27.0%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,401.50
7D
2.7%
1Y
-3.2%
Santen Pharmaceutical
Market Cap: JP¥617.5b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,919.50
7D
-1.9%
1Y
15.3%
Tsumura
Market Cap: JP¥280.4b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,761.00
7D
1.7%
1Y
12.4%
PeptiDream
Market Cap: JP¥121.6b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥941.30
7D
-6.0%
1Y
-44.2%